LICENSE AGREEMENTLicense Agreement • February 2nd, 2023 • Unicycive Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This License Agreement (this “Agreement”), effective as of February 1, 2023 (the “Effective Date”), is entered into by and between Unicycive Therapeutics Inc., a Delaware corporation having offices at 4300 El Camino Real, Suite #210, Los Altos, California (“Unicycive”) and Lotus International Pte. Ltd, a Singapore corporation having offices at 80 Robinson Road #02-00 Singapore 068898 (“Lotus”).
